GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK’s Blenrep combos are being reviewed in 14 nations. Credit: Magda Wygralak/Shutterstock. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for ...

The British multinational pharmaceutical and biotechnology company GSK has officially opened its new regional vaccine distribution centre in Abu Dhabi to serve the demand across the Gulf ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...

The UK on Thurs­day au­tho­rized GSK’s Blenrep to treat cer­tain mul­ti­ple myelo­ma pa­tients in two dif­fer­ent reg­i­mens, mark­ing the drug’s first ap­proval world­wide ...

(Alliance News) - GSK PLC on Thursday said it has received authorisation from the UK Medicines & Healthcare products Regulatory Agency for Blenrep combinations in the treatment of adults with ...

‘Wolf of Wall Street’ explains why Trump isn’t guilty of ‘market manipulation’ While some of those have since been rolled back - at least temporarily - aluminium, steel and auto parts ...

GSK has secured the first regulatory approval for Blenrep since the antibody-drug conjugate’s global market withdrawal in 2022. The U.K.’s Medicines and Healthcare products Regulatory Agency ...

The recommendation also includes GSK plc’s (NYSE:GSK) Arexvy in adults aged 50-59 who are at increased risk for severe RSV disease. This expands on ACIP’s previous vote in June 2024 to ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to ...